Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2

Title
Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
Authors
Keywords
tralokinumab, crystal structure, antibody–antigen complex, mutagenesis, antibody structure
Journal
JOURNAL OF MOLECULAR BIOLOGY
Volume 429, Issue 2, Pages 208-219
Publisher
Elsevier BV
Online
2016-12-10
DOI
10.1016/j.jmb.2016.12.005

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started